Compare Stocks → Bill Gates is all about this tiny $2 stock (From Timothy Sykes) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:ATMNASDAQ:KODNASDAQ:PRE Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATMRio2C$0.68+1.5%C$0.68C$0.57▼C$0.86C$57.62MN/A114,654 shs15,000 shsKODKodiak Sciences$3.30-11.8%$4.46$1.37▼$9.80$173.37M2.25349,539 shs442,495 shsPREPrenetics Global$5.80-0.9%$4.53$2.85▼$15.00$53.03M-0.28179,990 shs1,946 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATMRio20.00%0.00%0.00%0.00%0.00%KODKodiak Sciences0.00%-8.59%-4.90%-39.00%-41.39%PREPrenetics Global+0.07%-1.96%+81.94%+11.83%-56.53%Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (Ad)Man who spotted Apple at $1.49 says: "Buy These 6 AI Stocks."And these will be the biggest winnersMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATMRio2N/AN/AN/AN/AN/AN/AN/AN/AKODKodiak Sciences3.1226 of 5 stars2.90.00.04.62.03.31.3PREPrenetics Global1.2195 of 5 stars3.53.00.00.00.60.00.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATMRio2N/AN/AN/AN/AKODKodiak Sciences1.71Reduce$5.5066.67% UpsidePREPrenetics Global3.00Buy$9.0055.07% UpsideCurrent Analyst RatingsLatest ATM, RBW, PRE, and KOD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/4/2024KODKodiak SciencesUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$3.00 ➝ $5.004/4/2024PREPrenetics GlobalCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$10.00 ➝ $9.004/1/2024KODKodiak SciencesBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$2.00 ➝ $3.00(Data available from 5/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATMRio2N/AN/AN/AN/AN/AN/AKODKodiak SciencesN/AN/AN/AN/A$4.59 per shareN/APREPrenetics Global$21.74M2.44N/AN/A$23.00 per share0.25Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATMRio2N/AN/A0.00∞N/AN/AN/AN/AN/AKODKodiak Sciences-$260.49M-$4.43N/AN/AN/AN/A-81.11%-45.38%8/12/2024 (Estimated)PREPrenetics Global-$62.72M-$4.80N/A∞N/A-193.60%-11.15%-9.03%6/3/2024 (Estimated)Latest ATM, RBW, PRE, and KOD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/1/2024Q4 2023PREPrenetics GlobalN/A-$0.52-$0.52$0.53N/A$5.43 million3/28/2024Q4 2023KODKodiak Sciences-$0.86-$1.13-$0.27-$1.13N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATMRio2N/AN/AN/AN/AN/AKODKodiak SciencesN/AN/AN/AN/AN/APREPrenetics GlobalN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATMRio2N/AN/AN/AKODKodiak SciencesN/A10.126.93PREPrenetics GlobalN/A2.372.29OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATMRio2N/AKODKodiak Sciences89.06%PREPrenetics Global25.01%Insider OwnershipCompanyInsider OwnershipATMRio2N/AKODKodiak Sciences45.30%PREPrenetics Global7.80%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableATMRio2N/A84.74 millionN/ANot OptionableKODKodiak Sciences11652.53 million28.74 millionOptionablePREPrenetics Global4009.14 million8.42 millionNot OptionableATM, RBW, PRE, and KOD HeadlinesRecent News About These CompaniesMay 18 at 3:46 AM | americanbankingnews.comPrenetics Global (NASDAQ:PRE) Trading Down 0.8%May 17 at 1:56 AM | americanbankingnews.comContrasting Prenetics Global (NASDAQ:PRE) & Rapid Micro Biosystems (NASDAQ:RPID)April 26, 2024 | zawya.comAitrasound® Medical Group Announces Completion of a Pre-A Financing Round of Nearly 60 Million Hong Kong DollarsApril 26, 2024 | schaeffersresearch.comDow Down Triple Digits; Tesla Props Up NasdaqApril 6, 2024 | benzinga.comPrenetics Global Stock (NASDAQ:PRE), Analyst Ratings, Price Targets, PredictionsApril 3, 2024 | baystreet.caPrenetics Flat on Financial ResultsApril 1, 2024 | finanznachrichten.dePrenetics Global Limited: Prenetics Announces Fourth Quarter and Full Year 2023 Financial ResultsApril 1, 2024 | benzinga.comPrenetics Global: Q4 Earnings InsightsApril 1, 2024 | investorplace.comPRE Stock Earnings: Prenetics Global Beats EPS, Misses Revenue for Q4 2023April 1, 2024 | globenewswire.comPrenetics Announces Fourth Quarter and Full Year 2023 Financial ResultsFebruary 9, 2024 | finance.yahoo.comPrenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space StationFebruary 9, 2024 | globenewswire.comPrenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space StationJanuary 17, 2024 | msn.comPrenetics Global files to sell 1.48M Class A shares for holdersDecember 18, 2023 | investing.comPrenetics Global (PRE) Earnings Dates & ReportsDecember 17, 2023 | seekingalpha.comPRENW Prenetics Global Limited WT EXP 051827November 20, 2023 | benzinga.comPrenetics Global Stock (NASDAQ:PRE) Insider TradesNovember 20, 2023 | msn.comPrenetics Global GAAP EPS of -$0.08, revenue of $4.86MNovember 20, 2023 | benzinga.comPrenetics Global: Q3 Earnings InsightsNovember 20, 2023 | finance.yahoo.comPrenetics Announces Third Quarter 2023 Financial ResultsNovember 11, 2023 | finance.yahoo.comPrenetics Global Limited (NASDAQ:PRE): Is Breakeven Near?New MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesHow to Use Put Debit Spreads to Profit From Falling Stocks April 26, 2024 9:30 AMView How to Use Put Debit Spreads to Profit From Falling Stocks Power Surge: Utilities Sector's Resilience ShinesApril 25, 2024 9:51 AMView Power Surge: Utilities Sector's Resilience ShinesBeyond the Halving: The Future of Bitcoin Mining StocksApril 23, 2024 9:50 AMView Beyond the Halving: The Future of Bitcoin Mining StocksHow to Buy the Dip and Sell the Rip on Your Stocks with OptionsMay 15, 2024 10:30 AMView How to Buy the Dip and Sell the Rip on Your Stocks with OptionsChinese Stocks Stage Impressive ReboundMay 6, 2024 7:45 AMView Chinese Stocks Stage Impressive ReboundAll HeadlinesCompany DescriptionsRio2CVE:ATMAtacama Pacific Gold Corporation, an exploration stage company, engages in the acquisition, exploration, and development of gold properties in Chile. The company principally holds a 100% interest in the Cerro Maricunga gold project located in Region III northeast of the city of Copiapo. Atacama Pacific Gold Corporation was incorporated in 2008 and is headquartered in Toronto, Canada.Kodiak SciencesNASDAQ:KODKodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.Prenetics GlobalNASDAQ:PREPrenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.